Lab-Grown Chocolate Set for 2027 Debut
Lab-grown chocolate is expected to hit shelves in 2027, with major brands like Oreo, Cadbury, and Toblerone funding Israeli biotech firms to develop the technology. The move is driven by potential cost efficiencies over traditional cocoa farming and could signal a major shift in food supply chains.
The investment by Mondelēz International, owner of Cadbury and Toblerone, into Israeli startup Celleste Bio is a direct response to extreme cocoa price volatility. After cocoa futures peaked at an all-time high of $12,906 per metric ton in December 2024, the market saw a sharp decline to $3,587 by February 2026, creating massive financial uncertainty for major confectionary producers. Cellular agriculture offers a potential hedge against these market fluctuations and climate-related supply chain disruptions. Traditional cocoa farming is threatened by climate change, crop diseases like Cocoa Swollen Shoot Virus, and an aging population of trees in West Africa, which supplies the majority of the world's cocoa. Lab-based production promises a stable, year-round supply resilient to weather events and pests. The technology, developed by firms like Celleste Bio and fellow Israeli startup Kokomodo, involves cultivating cells from cocoa beans in bioreactors. This process can generate bio-identical cocoa butter, the most expensive ingredient in chocolate, with significantly fewer resources. Celleste Bio claims its method can produce the equivalent of four tonnes of cocoa butter from just one or two beans, a process that would traditionally require 10,000 square meters of land. This move into cellular agriculture is also a strategic play to address mounting environmental, social, and governance (ESG) pressures. Conventional cocoa farming is a major driver of deforestation, particularly in Côte d'Ivoire and Ghana. By localizing production and reducing land use, lab-grown chocolate offers a narrative of sustainability and a potentially smaller carbon footprint, which is increasingly important to investors and consumers. However, scaling the technology to achieve price parity with conventionally grown cocoa remains a significant hurdle. Celleste Bio aims to have a pilot facility with a 1,000-liter capacity ready by 2027 and is currently navigating the regulatory approval process in the U.S., EU, UK, and Israel. Consumer acceptance will be the final test for the market viability of lab-grown chocolate. While awareness of cellular agriculture is growing, consumer willingness to try such products is heavily dependent on assurances of safety and trust in regulation. The industry's choice of terminology, favoring "cell-cultivated" over "lab-grown," reflects a conscious effort to manage public perception and overcome psychological barriers like food neophobia.
